- Cancer Drugs
- Diabetes Drugs
- Mental Illness Drugs
- Cardiovascular Disease Drugs
- Hypertension Drugs
- Inflammation Drugs
- Allergy Drugs
- Central Nervous System Drugs
- Neurology Drugs
- Asthma Drugs
- Hepatitis Drugs
- Arthritis Drugs
- Osteoporosis Drugs
- Tuberculosis Drugs
- Malaria Drugs
- Alzheimer Drugs
- Parkinson Disease Drugs
- HIV
- Multiple Sclerosis Drugs
- Autoimmune Drugs
- Insomnia Drugs
- Obesity Drugs
- Gaucher Drugs
- Anemia Drugs
- Crohn Drugs
- Huntington Drugs
- Paget Drugs
Diseases & treatment Market Research Reports
Title | published | price | |
---|---|---|---|
Global Raloxifene Hydrochloride Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 CountriesBy Maia Research "...... as xx Million USD in 2016, grew to xx Million USD in 2020, and will reach xx Million USD in 2026, with a CAGR of xx during 2020-2026.
Global Raloxifene Hydrochloride Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Anal......" | 16-Nov-2021 | $4000 | |
Immunotherapy Drugs Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... was valued at 199340 million in 2020 and is projected to reach US$ 293380 million by 2027, at a CAGR of 10.1% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Immunotherapy Drugs companies, and industry expe......" | 15-Nov-2021 | $3250 | |
China Ivermectin Market Report & Forecast 2021-2027By QYResearch Group "...... ts)
China Ivermectin Market Segment Percentages, By Application, 2020 (%)
- Cow
- Sheep
- Pig
- Poultry
- Others
Competitor Analysis
The report also provides analysis of leading market p......" | 15-Nov-2021 | $3400 | |
Global Hypolipidemic Drugs Market Size, Status and Forecast 2021-2027By QYResearch Group "...... t as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
- Cholic Acid Regulator
- HMG-CoA Redu......" | 15-Nov-2021 | $3900 | |
China Levofloxacin Market Report & Forecast 2021-2027By QYResearch Group "...... Units)
China Levofloxacin Market Segment Percentages, By Application, 2020 (%)
- Pneumonia
- Skin Infection
- Kidney Infection
- Bladder Infection
- Others
Competitor Analysis
The report......" | 15-Nov-2021 | $3400 | |
Pinaverium Bromide Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... op five Pinaverium Bromide companies in 2020 (%)
The global Pinaverium Bromide market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR G......" | 15-Nov-2021 | $3250 | |
Lincomycin Hydrochloride Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... T)
Global top five Lincomycin Hydrochloride companies in 2020 (%)
The global Lincomycin Hydrochloride market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period......." | 15-Nov-2021 | $3250 | |
Tamoxifen Citrate Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... five Tamoxifen Citrate companies in 2020 (%)
The global Tamoxifen Citrate market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL......" | 15-Nov-2021 | $3250 | |
Topiramate Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... nies in 2020 (%)
The global Topiramate market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Topira......" | 15-Nov-2021 | $3250 | |
Kidney Cancer Drugs Market - Global Outlook and Forecast 2021-2027By Market Monitor Global "...... obal top five Kidney Cancer Drugs companies in 2020 (%)
The global Kidney Cancer Drugs market was valued at 4085 million in 2020 and is projected to reach US$ 4800.1 million by 2027, at a CAGR of 4.1% during the forecast period.
M......" | 15-Nov-2021 | $3250 | |
|